CiiTA to attend the Medicaid Drug Rebate Conference later this month.

This September 23-25, CiiTA will join experts from around the country to discuss government pricing, rebates, and regulations. As the nationally recognized and neutral thought leader on the 340B Drug Pricing Program, CiiTA has a seat at the table to address the unique impacts 340B presents to Medicaid plan implementation and success.

CiiTA’s conference space—Booth 20—will act as a hub for Medicaid plan providers contending with the regulatory and administrative challenges of the 340B Program. It will also serve as a solution center for pharmaceutical manufacturers balancing their covered entity partnerships and duplicate discount risks.

Medicaid and 340B don’t need to be at odds with one another. Come learn how CiiTA works with Medicaid plan providers, pharmaceutical manufacturers and covered entities to reconcile the challenges of duplicate discounting through our Good Faith Inquiry offering and Astrolabe Claims Clearinghouse.

Want to learn more about the conference? Get the download.

Looking to learn more about CiiTA? Contact us any time.